AP 0 2 0 2 B-clinical_variable
≤ 3 4 3 4 O
2.5 5 8 5 8 B-upper_bound
x 9 10 9 10 I-upper_bound
ULN 11 14 11 14 B-clinical_variable
( 15 16 15 16 O
≤ 16 17 16 17 O
5 18 19 18 19 O
x 20 21 20 21 O
ULN 22 25 22 25 O
if 26 28 26 28 O
disease 29 36 29 36 O
- 36 37 36 37 O
related 37 44 37 44 O
) 44 45 44 45 O

AST 0 3 46 49 B-clinical_variable
and 4 7 50 53 O
ALT 8 11 54 57 B-clinical_variable
≤ 12 13 58 59 O
3.0 14 17 60 63 B-upper_bound
x 18 19 64 65 I-upper_bound
ULN 20 23 66 69 I-upper_bound
, 23 24 69 70 O
independently 25 38 71 84 O
of 39 41 85 87 O
the 42 45 88 91 O
presence 46 54 92 100 O
of 55 57 101 103 O
liver 58 63 104 109 B-cancer
metastases 64 74 110 120 I-cancer

Active 0 6 121 127 O
uncontrolled 7 19 128 140 B-chronic_disease
infection 20 29 141 150 I-chronic_disease
[ 30 31 151 152 O
i.e. 31 35 152 156 O
, 35 36 156 157 O
antibiotic 37 47 158 168 B-treatment
, 47 48 168 169 O
antifungal 49 59 170 180 B-treatment
or 60 62 181 183 O
antiviral 63 72 184 193 B-treatment
intervention 73 85 194 206 I-treatment
indicated 86 95 207 216 O
or 96 98 217 219 O
surgical 99 107 220 228 B-treatment
procedure 108 117 229 238 I-treatment
( 118 119 239 240 O
i.e. 119 123 240 244 O
, 123 124 244 245 O
pleural 125 132 246 253 O
or 133 135 254 256 O
deep 136 140 257 261 O
abscess 141 148 262 269 O
drainage 149 157 270 278 O
) 157 158 278 279 O
conducted 159 168 280 289 O
within 169 175 290 296 O
15 176 178 297 299 B-upper_bound
days 179 183 300 304 I-upper_bound
prior 184 189 305 310 I-upper_bound
to 190 192 311 313 O
inclusion 193 202 314 323 O
] 202 203 323 324 O

Adenocarcinoma 0 14 325 339 B-cancer
or 15 17 340 342 O
carcinoma 18 27 343 352 O
of 28 30 353 355 O
unknown 31 38 356 363 O
primary 39 46 364 371 O
site 47 51 372 376 O
( 52 53 377 378 O
UKPS 53 57 378 382 O
) 57 58 382 383 O

Adequate 0 8 384 392 O
bone 9 13 393 397 O
marrow 14 20 398 404 O
, 20 21 404 405 O
renal 22 27 406 411 O
, 27 28 411 412 O
hepatic 29 36 413 420 O
, 36 37 420 421 O
and 38 41 422 425 O
metabolic 42 51 426 435 O
function 52 60 436 444 O
( 61 62 445 446 O
assessed 62 70 446 454 O
≤ 71 72 455 456 O
7 73 74 457 458 B-upper_bound
days 75 79 459 463 I-upper_bound
before 80 86 464 470 I-upper_bound
inclusion 87 96 471 480 O
in 97 99 481 483 O
the 100 103 484 487 O
study 104 109 488 493 O
) 109 110 493 494 O

Age 0 3 495 498 B-age
≥ 4 5 499 500 O
18 6 8 501 503 B-lower_bound
years 9 14 504 509 I-lower_bound

Albumin 0 7 510 517 B-clinical_variable
≥ 8 9 518 519 O
2.5 10 13 520 523 B-lower_bound
g 14 15 524 525 I-lower_bound
/ 15 16 525 526 I-lower_bound
dl 16 18 526 528 I-lower_bound

Biliary 0 7 529 536 B-cancer
tract 8 13 537 542 I-cancer
adenocarcinoma 14 28 543 557 I-cancer

Breast 0 6 558 564 B-cancer
cancer 7 13 565 571 I-cancer
non 14 17 572 575 O
- 17 18 575 576 O
candidate 18 27 576 585 O
for 28 31 586 589 O
hormone 32 39 590 597 B-treatment
therapy 40 47 598 605 I-treatment
alone 48 53 606 611 O

Calculated 0 10 612 622 B-clinical_variable
creatinine 11 21 623 633 I-clinical_variable
clearance 22 31 634 643 I-clinical_variable
( 32 33 644 645 I-clinical_variable
CrCl 33 37 645 649 I-clinical_variable
) 37 38 649 650 I-clinical_variable
≥ 39 40 651 652 O
50 41 43 653 655 B-lower_bound
ml 44 46 656 658 I-lower_bound
/ 46 47 658 659 I-lower_bound
minute 47 53 659 665 I-lower_bound
( 54 55 666 667 O
using 55 60 667 672 O
Cockcroft 61 70 673 682 O
and 71 74 683 686 O
Gault 75 80 687 692 O
's 80 82 692 694 O
formula 83 90 695 702 O
; 90 91 702 703 O
see 92 95 704 707 O
APPENDIX 96 104 708 716 O
2 105 106 717 718 O
) 106 107 718 719 O

Cervix 0 6 720 726 B-cancer
carcinoma 7 16 727 736 I-cancer

Concomitant 0 11 737 748 B-chronic_disease
diseases 12 20 749 757 I-chronic_disease
/ 20 21 757 758 I-chronic_disease
conditions 21 31 758 768 I-chronic_disease

Current 0 7 769 776 O
or 8 10 777 779 O
prior 11 16 780 785 O
history 17 24 786 793 O
of 25 27 794 796 O
grade 28 33 797 802 O
≥ 34 35 803 804 O
2 36 37 805 806 B-lower_bound
peripheral 38 48 807 817 B-chronic_disease
sensory 49 56 818 825 I-chronic_disease
and/or 57 63 826 832 O
motor 64 69 833 838 B-chronic_disease
neuropathy 70 80 839 849 I-chronic_disease

Documented 0 10 850 860 O
disease 11 18 861 868 O
progression 19 30 869 880 O
during 31 37 881 887 O
or 38 40 888 890 O
immediately 41 52 891 902 O
after 53 58 903 908 B-treatment
last 59 63 909 913 I-treatment
therapy 64 71 914 921 I-treatment
according 72 81 922 931 O
to 82 84 932 934 O
any 85 88 935 938 O
of 89 91 939 941 O
the 92 95 942 945 O
aforementioned 96 110 946 960 O
criteria 111 119 961 969 O

Eastern 0 7 970 977 B-clinical_variable
Cooperative 8 19 978 989 I-clinical_variable
Oncology 20 28 990 998 I-clinical_variable
Group 29 34 999 1004 I-clinical_variable
( 35 36 1005 1006 I-clinical_variable
ECOG 36 40 1006 1010 I-clinical_variable
) 40 41 1010 1011 I-clinical_variable
performance 42 53 1012 1023 I-clinical_variable
status 54 60 1024 1030 I-clinical_variable
( 61 62 1031 1032 I-clinical_variable
PS 62 64 1032 1034 I-clinical_variable
) 64 65 1034 1035 I-clinical_variable
of 66 68 1036 1038 O
≤ 69 70 1039 1040 O
1 71 72 1041 1042 B-upper_bound
( 73 74 1043 1044 O
see 74 77 1044 1047 O
APPENDIX 78 86 1048 1056 O
1 87 88 1057 1058 O
) 88 89 1058 1059 O

Epithelial 0 10 1060 1070 B-cancer
ovarian 11 18 1071 1078 I-cancer
cancer 19 25 1079 1085 I-cancer
( 26 27 1086 1087 O
including 27 36 1087 1096 O
primary 37 44 1097 1104 O
peritoneal 45 55 1105 1115 B-cancer
disease 56 63 1116 1123 I-cancer
and/or 64 70 1124 1130 O
fallopian 71 80 1131 1140 B-cancer
tube 81 85 1141 1145 I-cancer
carcinomas 86 96 1146 1156 I-cancer
and/or 97 103 1157 1163 O
endometrial 104 115 1164 1175 B-cancer
adenocarcinomas 116 131 1176 1191 I-cancer
) 131 132 1191 1192 O

Evaluable 0 9 1193 1202 O
disease 10 17 1203 1210 O
by 18 20 1211 1213 O
serum 21 26 1214 1219 O
markers 27 34 1220 1227 O
in 35 37 1228 1230 O
the 38 41 1231 1234 O
case 42 46 1235 1239 O
of 47 49 1240 1242 O
ovarian 50 57 1243 1250 B-cancer
cancer 58 64 1251 1257 I-cancer
[ 65 66 1258 1259 O
Gynecologic 66 77 1259 1270 O
Cancer 78 84 1271 1277 O
Intergroup 85 95 1278 1288 O
( 96 97 1289 1290 O
GCIG 97 101 1290 1294 O
) 101 102 1294 1295 O
specific 103 111 1296 1304 O
criteria 112 120 1305 1313 O
] 120 121 1313 1314 O

Gastrointestinal 0 16 1315 1331 B-cancer
stromal 17 24 1332 1339 I-cancer
tumor 25 30 1340 1345 I-cancer
( 31 32 1346 1347 I-cancer
GIST 32 36 1347 1351 I-cancer
) 36 37 1351 1352 I-cancer

Germ 0 4 1353 1357 B-cancer
cell 5 9 1358 1362 I-cancer
tumors 10 16 1363 1369 I-cancer
( 17 18 1370 1371 I-cancer
GCTs 18 22 1371 1375 I-cancer
) 22 23 1375 1376 I-cancer

History 0 7 1377 1384 O
or 8 10 1385 1387 O
presence 11 19 1388 1396 O
of 20 22 1397 1399 O
unstable 23 31 1400 1408 B-chronic_disease
angina 32 38 1409 1415 I-chronic_disease
, 38 39 1415 1416 O
myocardial 40 50 1417 1427 B-chronic_disease
infarction 51 61 1428 1438 I-chronic_disease
, 61 62 1438 1439 O
congestive 63 73 1440 1450 B-chronic_disease
heart 74 79 1451 1456 I-chronic_disease
failure 80 87 1457 1464 I-chronic_disease
, 87 88 1464 1465 O
or 89 91 1466 1468 O
clinically 92 102 1469 1479 B-chronic_disease
significant 103 114 1480 1491 I-chronic_disease
valvular 115 123 1492 1500 I-chronic_disease
heart 124 129 1501 1506 I-chronic_disease
disease 130 137 1507 1514 I-chronic_disease
within 138 144 1515 1521 O
last 145 149 1522 1526 B-upper_bound
year 150 154 1527 1531 I-upper_bound

In 0 2 1532 1534 O
the 3 6 1535 1538 O
case 7 11 1539 1543 O
of 12 14 1544 1546 O
hormonesensitive 15 31 1547 1563 B-cancer
breast 32 38 1564 1570 I-cancer
cancer 39 45 1571 1577 I-cancer
progressing 46 57 1578 1589 O
while 58 63 1590 1595 O
on 64 66 1596 1598 O
hormone 67 74 1599 1606 B-treatment
therapy 75 82 1607 1614 I-treatment
, 82 83 1614 1615 O
the 84 87 1616 1619 O
latter 88 94 1620 1626 O
must 95 99 1627 1631 O
be 100 102 1632 1634 O
either 103 109 1635 1641 O
stopped 110 117 1642 1649 O
up 118 120 1650 1652 O
to 121 123 1653 1655 O
one 124 127 1656 1659 O
week 128 132 1660 1664 O
before 133 139 1665 1671 O
or 140 142 1672 1674 O
continued 143 152 1675 1684 O
without 153 160 1685 1692 O
changes 161 168 1693 1700 O
during 169 175 1701 1707 O
the 176 179 1708 1711 O
trial 180 185 1712 1717 O

International 0 13 1718 1731 B-clinical_variable
Normalized 14 24 1732 1742 I-clinical_variable
Ratio 25 30 1743 1748 I-clinical_variable
( 31 32 1749 1750 I-clinical_variable
INR 32 35 1750 1753 I-clinical_variable
) 35 36 1753 1754 I-clinical_variable
< 37 38 1755 1756 O
1.5 39 42 1757 1760 B-upper_bound
( 43 44 1761 1762 O
except 44 50 1762 1768 O
if 51 53 1769 1771 O
patient 54 61 1772 1779 O
is 62 64 1780 1782 O
on 65 67 1783 1785 O
oral 68 72 1786 1790 B-treatment
anticoagulation 73 88 1791 1806 I-treatment
therapy 89 96 1807 1814 I-treatment
) 96 97 1814 1815 O

Known 0 5 1816 1821 O
chronic 6 13 1822 1829 O
active 14 20 1830 1836 O
hepatitis 21 30 1837 1846 B-chronic_disease
or 31 33 1847 1849 O
cirrhosis 34 43 1850 1859 B-chronic_disease

Known 0 5 1860 1865 O
human 6 11 1866 1871 B-chronic_disease
immunodeficiency 12 28 1872 1888 I-chronic_disease
virus 29 34 1889 1894 I-chronic_disease
( 35 36 1895 1896 I-chronic_disease
HIV 36 39 1896 1899 I-chronic_disease
) 39 40 1899 1900 I-chronic_disease
infection 41 50 1901 1910 I-chronic_disease

Known 0 5 1911 1916 O
hypersensitivity 6 22 1917 1933 O
to 23 25 1934 1936 O
gemcitabine 26 37 1937 1948 B-allergy_name
or 38 40 1949 1951 O
any 41 44 1952 1955 O
component 45 54 1956 1965 O
of 55 57 1966 1968 O
the 58 61 1969 1972 O
formulation 62 73 1973 1984 O

Left 0 4 1985 1989 B-clinical_variable
ventricular 5 16 1990 2001 I-clinical_variable
ejection 17 25 2002 2010 I-clinical_variable
fraction 26 34 2011 2019 I-clinical_variable
( 35 36 2020 2021 I-clinical_variable
LVEF 36 40 2021 2025 I-clinical_variable
) 40 41 2025 2026 I-clinical_variable
by 42 44 2027 2029 O
echocardiography 45 61 2030 2046 O
( 62 63 2047 2048 O
ECHO 63 67 2048 2052 O
) 67 68 2052 2053 O

Life 0 4 2054 2058 B-clinical_variable
expectancy 5 15 2059 2069 I-clinical_variable
≥ 16 17 2070 2071 O
3 18 19 2072 2073 B-lower_bound
months 20 26 2074 2080 I-lower_bound

Limitation 0 10 2081 2091 O
of 11 13 2092 2094 O
the 14 17 2095 2098 O
patient 18 25 2099 2106 O
's 25 27 2106 2108 O
ability 28 35 2109 2116 O
to 36 38 2117 2119 O
comply 39 45 2120 2126 O
with 46 50 2127 2131 O
the 51 54 2132 2135 O
treatment 55 64 2136 2145 B-treatment
or 65 67 2146 2148 O
follow 68 74 2149 2155 O
- 74 75 2155 2156 O
up 75 77 2156 2158 O
protocol 78 86 2159 2167 O

Locally 0 7 2168 2175 O
advanced 8 16 2176 2184 O
or 17 19 2185 2187 O
metastatic 20 30 2188 2198 B-cancer
head 31 35 2199 2203 I-cancer
and 36 39 2204 2207 O
neck 40 44 2208 2212 B-cancer
cancer 45 51 2213 2219 I-cancer

Measurable 0 10 2220 2230 O
disease 11 18 2231 2238 O
according 19 28 2239 2248 O
to 29 31 2249 2251 O
RECIST 32 38 2252 2258 O
v.1.1 39 44 2259 2264 O
( 45 46 2265 2266 O
or 46 48 2266 2268 O
Choi 49 53 2269 2273 O
criteria 54 62 2274 2282 O
and/or 63 69 2283 2289 O
EORTC 70 75 2290 2295 O
metabolic 76 85 2296 2305 O
response 86 94 2306 2314 O
criteria 95 103 2315 2323 O
for 104 107 2324 2327 O
solid 108 113 2328 2333 B-cancer
tumors 114 120 2334 2340 I-cancer
, 120 121 2340 2341 O
in 122 124 2342 2344 O
the 125 128 2345 2348 O
case 129 133 2349 2353 O
of 134 136 2354 2356 O
GIST 137 141 2357 2361 B-cancer
) 141 142 2361 2362 O

Men 0 3 2363 2366 B-gender
or 4 6 2367 2369 I-gender
women 7 12 2370 2375 I-gender
of 13 15 2376 2378 O
childbearing 16 28 2379 2391 O
potential 29 38 2392 2401 O
who 39 42 2402 2405 O
are 43 46 2406 2409 O
not 47 50 2410 2413 B-contraception_consent
using 51 56 2414 2419 I-contraception_consent
an 57 59 2420 2422 I-contraception_consent
effective 60 69 2423 2432 I-contraception_consent
method 70 76 2433 2439 I-contraception_consent
of 77 79 2440 2442 I-contraception_consent
contraception 80 93 2443 2456 I-contraception_consent
as 94 96 2457 2459 O
previously 97 107 2460 2470 O
described 108 117 2471 2480 O

Non 0 3 2481 2484 B-cancer
- 3 4 2484 2485 I-cancer
small 4 9 2485 2490 I-cancer
cell 10 14 2491 2495 I-cancer
lung 15 19 2496 2500 I-cancer
cancer 20 26 2501 2507 I-cancer
( 27 28 2508 2509 I-cancer
NSCLC 28 33 2509 2514 I-cancer
) 33 34 2514 2515 I-cancer

Patients 0 8 2516 2524 O
who 9 12 2525 2528 O
have 13 17 2529 2533 O
had 18 21 2534 2537 O
RT 22 24 2538 2540 B-treatment
in 25 27 2541 2543 O
more 28 32 2544 2548 O
than 33 37 2549 2553 O
35 38 40 2554 2556 B-lower_bound
% 40 41 2556 2557 I-lower_bound
of 42 44 2558 2560 O
the 45 48 2561 2564 O
bone 49 53 2565 2569 B-clinical_variable
marrow 54 60 2570 2576 I-clinical_variable

Patients 0 8 2577 2585 O
who 9 12 2586 2589 O
have 13 17 2590 2594 O
previously 18 28 2595 2605 O
discontinued 29 41 2606 2618 O
gemcitabine 42 53 2619 2630 B-treatment
- 53 54 2630 2631 O
containing 54 64 2631 2641 O
regimens 65 73 2642 2650 O
due 74 77 2651 2654 O
to 78 80 2655 2657 O
gemcitabine 81 92 2658 2669 O
- 92 93 2669 2670 O
related 93 100 2670 2677 O
toxicity 101 109 2678 2686 O

Patients 0 8 2687 2695 O
with 9 13 2696 2700 O
a 14 15 2701 2702 O
histologically 16 30 2703 2717 O
/ 30 31 2717 2718 O
cytologically 31 44 2718 2731 O
confirmed 45 54 2732 2741 O
diagnosis 55 64 2742 2751 O
of 65 67 2752 2754 O
advanced 68 76 2755 2763 O
disease 77 84 2764 2771 O
of 85 87 2772 2774 O
any 88 91 2775 2778 O
of 92 94 2779 2781 O
the 95 98 2782 2785 O
following 99 108 2786 2795 O
tumors 109 115 2796 2802 B-cancer
that 116 120 2803 2807 O
progressed 121 131 2808 2818 O
to 132 134 2819 2821 O
standard 135 143 2822 2830 B-treatment
therapy 144 151 2831 2838 I-treatment
or 152 154 2839 2841 O
for 155 158 2842 2845 O
whom 159 163 2846 2850 O
no 164 166 2851 2853 O
standard 167 175 2854 2862 O
therapy 176 183 2863 2870 O
exists 184 190 2871 2877 O

Platelet 0 8 2878 2886 B-clinical_variable
count 9 14 2887 2892 I-clinical_variable
≥ 15 16 2893 2894 O
100 17 20 2895 2898 B-lower_bound
x 21 22 2899 2900 I-lower_bound
109 23 26 2901 2904 I-lower_bound
/ 26 27 2904 2905 I-lower_bound
l 27 28 2905 2906 I-lower_bound
, 28 29 2906 2907 O
hemoglobin 30 40 2908 2918 B-clinical_variable
≥ 41 42 2919 2920 O
9.0 43 46 2921 2924 B-lower_bound
g 47 48 2925 2926 I-lower_bound
/ 48 49 2926 2927 I-lower_bound
dl 49 51 2927 2929 I-lower_bound
and 52 55 2930 2933 O
ANC 56 59 2934 2937 B-clinical_variable
≥ 60 61 2938 2939 O
1.0 62 65 2940 2943 B-lower_bound
x 66 67 2944 2945 I-lower_bound
109 68 71 2946 2949 I-lower_bound
/ 71 72 2949 2950 I-lower_bound
l 72 73 2950 2951 I-lower_bound

Prior 0 5 2952 2957 O
treatment 6 15 2958 2967 O
with 16 20 2968 2972 O
PM060184 21 29 2973 2981 B-treatment

Prior 0 5 2982 2987 B-treatment
treatment 6 15 2988 2997 I-treatment
with 16 20 2998 3002 O
gemcitabine 21 32 3003 3014 B-treatment
- 32 33 3014 3015 I-treatment
containing 33 43 3015 3025 I-treatment
therapy 44 51 3026 3033 I-treatment
for 52 55 3034 3037 O
advanced 56 64 3038 3046 O
disease 65 72 3047 3054 O
( 73 74 3055 3056 O
adjuvant 74 82 3056 3064 B-treatment
therapy 83 90 3065 3072 I-treatment
is 91 93 3073 3075 O
allowed 94 101 3076 3083 O
, 101 102 3083 3084 O
provided 103 111 3085 3093 O
not 112 115 3094 3097 O
more 116 120 3098 3102 O
than 121 125 3103 3107 O
six 126 129 3108 3111 B-upper_bound
cycles 130 136 3112 3118 I-upper_bound
were 137 141 3119 3123 O
administered 142 154 3124 3136 O
and 155 158 3137 3140 O
relapse 159 166 3141 3148 O
occurred 167 175 3149 3157 O
more 176 180 3158 3162 O
than 181 185 3163 3167 O
six 186 189 3168 3171 B-lower_bound
months 190 196 3172 3178 I-lower_bound
after 197 202 3179 3184 O
the 203 206 3185 3188 O
last 207 211 3189 3193 O
drug 212 216 3194 3198 O
administration 217 231 3199 3213 O
) 231 232 3213 3214 O

Prior 0 5 3215 3220 O
treatment 6 15 3221 3230 O
with 16 20 3231 3235 O
oxaliplatin 21 32 3236 3247 B-treatment

Recovery 0 8 3248 3256 O
to 9 11 3257 3259 O
grade 12 17 3260 3265 O
≤ 18 19 3266 3267 O
1 20 21 3268 3269 B-upper_bound
from 22 26 3270 3274 O
any 27 30 3275 3278 O
AE 31 33 3279 3281 B-chronic_disease
derived 34 41 3282 3289 O
from 42 46 3290 3294 O
previous 47 55 3295 3303 O
treatment 56 65 3304 3313 O

Symptomatic 0 11 3314 3325 O
arrhythmia 12 22 3326 3336 B-chronic_disease
or 23 25 3337 3339 O
any 26 29 3340 3343 O
uncontrolled 30 42 3344 3356 O
arrhythmia 43 53 3357 3367 O
requiring 54 63 3368 3377 O
ongoing 64 71 3378 3385 O
treatment 72 81 3386 3395 B-treatment

Symptomatic 0 11 3396 3407 O
, 11 12 3407 3408 O
progressive 13 24 3409 3420 O
or 25 27 3421 3423 O
corticosteroids 28 43 3424 3439 O
- 43 44 3439 3440 O
requiring 44 53 3440 3449 O
documented 54 64 3450 3460 O
brain 65 70 3461 3466 B-cancer
metastases 71 81 3467 3477 I-cancer
or 82 84 3478 3480 O
leptomeningeal 85 99 3481 3495 B-cancer
disease 100 107 3496 3503 I-cancer
involvement 108 119 3504 3515 O

Total 0 5 3516 3521 O
bilirubin 6 15 3522 3531 B-clinical_variable
≤ 16 17 3532 3533 O
1.5 18 21 3534 3537 B-upper_bound
x 22 23 3538 3539 I-upper_bound
ULN 24 27 3540 3543 I-upper_bound

Treatment 0 9 3544 3553 B-treatment
with 10 14 3554 3558 I-treatment
any 15 18 3559 3562 I-treatment
investigational 19 34 3563 3578 I-treatment
product 35 42 3579 3586 I-treatment
within 43 49 3587 3593 O
30 50 52 3594 3596 B-upper_bound
days 53 57 3597 3601 I-upper_bound
before 58 64 3602 3608 O
the 65 68 3609 3612 O
first 69 74 3613 3618 O
infusion 75 83 3619 3627 O

Urothelial 0 10 3628 3638 B-cancer
cancer 11 17 3639 3645 I-cancer

Women 0 5 3646 3651 B-gender
of 6 8 3652 3654 O
childbearing 9 21 3655 3667 O
potential 22 31 3668 3677 O
must 32 36 3678 3682 O
have 37 41 3683 3687 O
a 42 43 3688 3689 O
negative 44 52 3690 3698 B-pregnancy
serum 53 58 3699 3704 I-pregnancy
or 59 61 3705 3707 I-pregnancy
urine 62 67 3708 3713 I-pregnancy
pregnancy 68 77 3714 3723 I-pregnancy
test 78 82 3724 3728 O
before 83 89 3729 3735 O
study 90 95 3736 3741 O
entry 96 101 3742 3747 O

alopecia 0 8 3748 3756 B-chronic_disease

at 0 2 3757 3759 O
least 3 8 3760 3765 O
four 9 13 3766 3770 B-lower_bound
weeks 14 19 3771 3776 I-lower_bound
since 20 25 3777 3782 O
the 26 29 3783 3786 O
last 30 34 3787 3791 O
MAb 35 38 3792 3795 B-treatment
- 38 39 3795 3796 I-treatment
containing 39 49 3796 3806 I-treatment
therapy 50 57 3807 3814 I-treatment

at 0 2 3815 3817 O
least 3 8 3818 3823 O
six 9 12 3824 3827 B-lower_bound
weeks 13 18 3828 3833 I-lower_bound
since 19 24 3834 3839 O
nitrosoureas 25 37 3840 3852 B-treatment
and 38 41 3853 3856 O
mitomycin 42 51 3857 3866 B-treatment
C 52 53 3867 3868 I-treatment
( 54 55 3869 3870 O
systemic 55 63 3870 3878 O
) 63 64 3878 3879 O

at 0 2 3880 3882 O
least 3 8 3883 3888 O
three 9 14 3889 3894 O
weeks 15 20 3895 3900 O
since 21 26 3901 3906 O
the 27 30 3907 3910 O
last 31 35 3911 3915 O
anticancer 36 46 3916 3926 B-treatment
therapy 47 54 3927 3934 I-treatment
, 54 55 3934 3935 O
including 56 65 3936 3945 O
radiation 66 75 3946 3955 B-treatment
therapy 76 83 3956 3963 I-treatment
( 84 85 3964 3965 I-treatment
RT 85 87 3965 3967 I-treatment
) 87 88 3967 3968 I-treatment
in 89 91 3969 3971 O
more 92 96 3972 3976 O
than 97 101 3977 3981 O
35 102 104 3982 3984 B-lower_bound
% 104 105 3984 3985 I-lower_bound
of 106 108 3986 3988 O
the 109 112 3989 3992 O
bone 113 117 3993 3997 O
marrow 118 124 3998 4004 O

at 0 2 4005 4007 O
least 3 8 4008 4013 O
three 9 14 4014 4019 B-lower_bound
weeks 15 20 4020 4025 I-lower_bound
since 21 26 4026 4031 O
the 27 30 4032 4035 O
last 31 35 4036 4040 O
biological 36 46 4041 4051 B-treatment
/ 46 47 4051 4052 O
investigational 47 62 4052 4067 B-treatment
therapy 63 70 4068 4075 I-treatment
[ 71 72 4076 4077 O
excluding 72 81 4077 4086 O
monoclonal 82 92 4087 4097 B-clinical_variable
antibodies 93 103 4098 4108 I-clinical_variable
( 104 105 4109 4110 I-clinical_variable
MAbs 105 109 4110 4114 I-clinical_variable
) 109 110 4114 4115 I-clinical_variable
] 110 111 4115 4116 O

cutaneous 0 9 4117 4126 B-chronic_disease
toxicity 10 18 4127 4135 I-chronic_disease

women 0 5 4136 4141 B-gender
who 6 9 4142 4145 O
are 10 13 4146 4149 B-pregnancy
pregnant 14 22 4150 4158 I-pregnancy
or 23 25 4159 4161 O
breast 26 32 4162 4168 O
feeding 33 40 4169 4176 O

